Urine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: The Singapore Chinese health study

British Journal of Nutrition

Volumn 115, Issue 9, 2016, Pages 1607-1615

  Talaei, Mohammad ^a   Lee, Bee L ^a   Ong, Choon N ^a   Van Dam, Rob M ^a,b,c   Yuan, Jian M ^d,e   Koh, Woon P ^a,f   Pan, An ^g  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f DUKE NUS MEDICAL SCHOOL   (Singapore)

^g HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Type 2 diabetes: Isoflavones: Lignans: Urine metabolites: Incidence

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; HEMOGLOBIN A1C; ISOFLAVONE; LIGNAN; PHYTOESTROGEN; GLYCITIN; ISOFLAVONE DERIVATIVE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLITE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGAPORE; URINALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNOLOGY; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL; URINE;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EQUOL; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; LIGNANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHYTOESTROGENS; RISK FACTORS; SINGAPORE;

EID: 84960125530     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114516000581     Document Type: Article

References (45)

1. Kwon DY, Daily JW 3rd, Kim HJ, et al. (2010) Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr Res 30, 1-13.
2. Talaei M & Pan A (2015) Role of phytoestrogens in prevention and management of type 2 diabetes. World J Diabetes 6, 271-283.
3. Cederroth CR & Nef S (2009) Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol 304, 30-42.
4. Adolphe JL, Whiting SJ, Juurlink BH, et al. (2010) Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. Br J Nutr 103, 929-938.
5. Behloul N & Wu G (2013) Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur J Pharmacol 698, 31-38.
6. Gilbert ER & Liu D (2013) Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic beta-cell function. Food Funct 4, 200-212.
7. Villegas R, Gao YT, Yang G, et al. (2008) Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr 87, 162-167.
8. Nanri A, Mizoue T, Takahashi Y, et al. (2010) Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J Nutr 140, 580-586.
9. Morimoto Y, Steinbrecher A, Kolonel LN, et al. (2011) Soy consumption is not protective against diabetes in Hawaii: The Multiethnic Cohort. Eur J Clin Nutr 65, 279-282.
10. Mueller NT, Odegaard AO, Gross MD, et al. (2012) Soy intake and risk of type 2 diabetes in Chinese Singaporeans [corrected]. Eur J Nutr 51, 1033-1040.
11. Zamora-Ros R, Forouhi NG, Sharp SJ, et al. (2013) The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: The EPIC-InterAct study. Diabetes Care 36, 3961-3970.
12. Bredsdorff L, Obel T, Dethlefsen C, et al. (2013) Urinary flavonoid excretion and risk of acute coronary syndrome in a nested case-control study. Am J Clin Nutr 98, 209-216.
13. Sun Q, Wedick NM, Pan A, et al. (2014) Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women. Diabetes Care 37, 1287-1295.
14. Hankin JH, Stram DO, Arakawa K, et al. (2001) Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer 39, 187-195.
15. Koh WP, Yuan JM, Sun CL, et al. (2003) Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 63, 573-578.
16. Seow A, Shi CY, Franke AA, et al. (1998) Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 7, 135-140.
17. Odegaard AO, Koh WP, Arakawa K, et al. (2010) Soft drink and juice consumption and risk of physician-diagnosed incident type 2 diabetes: The Singapore Chinese Health Study. Am J Epidemiol 171, 701-708.
18. Chen Z, Pereira MA, Seielstad M, et al. (2014) Joint effects of known type 2 diabetes susceptibility loci in genome-wide association study of Singapore Chinese: The Singapore Chinese Health Study. PLOS ONE 9, e87762.
19. Parker DL, Rybak ME & Pfeiffer CM (2012) Phytoestrogen biomonitoring: an extractionless LC-MS/MS method for measuring urinary isoflavones and lignans by use of atmospheric pressure photoionization (APPI). Anal Bioanal Chem 402, 1123-1136.
20. International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32, 1327-1334.
21. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33, Suppl. 1, S62-S69.
22. Cermak R, Durazzo A, Maiani G, et al. (2009) The influence of postharvest processing and storage of foodstuffs on the bioavailability of flavonoids and phenolic acids. Mol Nutr Food Res 53, Suppl. 2, S184-S193.
23. Franke AA, Halm BM, Kakazu K, et al. (2009) Phytoestrogenic isoflavonoids in epidemiologic and clinical research. Drug Test Anal 1, 14-21.
24. Ko KP, Kim CS, Ahn Y, et al. (2015) Plasma isoflavone concentration is associated with decreased risk of type 2 diabetes in Korean women but not men: results from the Korean Genome and Epidemiology Study. Diabetologia 58, 726-735.
25. Yamamoto S, Sobue T, Sasaki S, et al. (2001) Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131, 2741-2747.
26. Fraser GE, Franke AA, Jaceldo-Siegl K, et al. (2010) Reliability of serum and urinary isoflavone estimates. Biomarkers 15, 135-139.
27. Setchell KD & Cole SJ (2006) Method of defining equolproducer status and its frequency among vegetarians. J Nutr 136, 2188-2193.
28. Lee SA, Wen W, Xiang YB, et al. (2007) Assessment of dietary isoflavone intake among middle-aged Chinese men. J Nutr 137, 1011-1016.
29. Liu ZM, Chen YM & Ho SC (2011) Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am J Clin Nutr 93, 1092-1101.
30. Zhang YB, Chen WH, Guo JJ, et al. (2013) Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women-a meta-analysis. Nutrition 29, 8-14.
31. Zhang W, Wang X, Liu Y, et al. (2008) Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99, 1301-1309.
32. Billinsky J, Glew RA, Cornish SM, et al. (2013) No evidence of hypoglycemia or hypotension in older adults during 6 months of flax lignan supplementation in a randomized controlled trial: a safety evaluation. Pharm Biol 51, 778-782.
33. Chan SG, Ho SC, Kreiger N, et al. (2007) Dietary sources and determinants of soy isoflavone intake among midlife Chinese Women in Hong Kong. J Nutr 137, 2451-2455.
34. Zamora-Ros R, Knaze V, Lujan-Barroso L, et al. (2012) Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur J Clin Nutr 66, 932-941.
35. Tetens I, Turrini A, Tapanainen H, et al. (2013) Dietary intake and main sources of plant lignans in five European countries. Food Nutr Res 57, 10.3402/fnr.v57i0.19805.
36. Huang MH, Norris J, Han W, et al. (2012) Development of an updated phytoestrogen database for use with the SWAN food frequency questionnaire: intakes and food sources in a community-based, multiethnic cohort study. Nutr Cancer 64, 228-244.
37. Wu X, Cai H, Gao YT, et al. (2012) Correlations of urinary phytoestrogen excretion with lifestyle factors and dietary intakes among middle-aged and elderly Chinese women. Int J Mol Epidemiol Genet 3, 18-29.
38. Zhang X, Gao YT, Yang G, et al. (2012) Urinary isoflavonoids and risk of coronary heart disease. Int J Epidemiol 41, 1367-1375.
39. Talaei M, Koh WP, van Dam RM, et al. (2014) Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J Nutr 144, 921-928.
40. Franke AA, Hebshi SM, Pagano I, et al. (2010) Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention. Cancer Epidemiol Biomarkers Prev 19, 1775-1783.
41. Krogholm KS, Bysted A, Brantsaeter AL, et al. (2012) Evaluation of flavonoids and enterolactone in overnight urine as intake biomarkers of fruits, vegetables and beverages in the Inter99 cohort study using the method of triads. Br J Nutr 108, 1904-1912.
42. Jaceldo-Siegl K, Fraser GE, Chan J, et al. (2008) Validation of soy protein estimates from a food-frequency questionnaire with repeated 24-h recalls and isoflavonoid excretion in overnight urine in a Western population with a wide range of soy intakes. Am J Clin Nutr 87, 1422-1427.
43. Tseng M, Olufade T, Kurzer MS, et al. (2008) Food frequency questionnaires and overnight urines are valid indicators of daidzein and genistein intake in U.S. women relative to multiple 24-h urine samples. Nutr Cancer 60, 619-626.
44. Manach C, Williamson G, Morand C, et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S-242S.
45. Kuijsten A, Arts IC, Vree TB, et al. (2005) Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 135, 795-801.